151 related articles for article (PubMed ID: 38484738)
1. A novel immune-related lncRNA signature predicts the prognosis and immune landscape in ccRCC.
Dai L; Pan D; Jin J; Lv W
Aging (Albany NY); 2024 Mar; 16(6):5149-5162. PubMed ID: 38484738
[TBL] [Abstract][Full Text] [Related]
2. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
[TBL] [Abstract][Full Text] [Related]
3. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
[TBL] [Abstract][Full Text] [Related]
4. A Novel Tumor Mutation Burden Related lncRNA Signature Identified Prognosis and Tumor Immune Microenvironment Features in Clear Cell Renal Cell Carcinoma.
Lin L; Wu XH; Zhu JM; Chen SH; Chen YH; Lin F; Xue XY; Wei Y; Xu N; Zheng QS; Sun XL
Comb Chem High Throughput Screen; 2023; 26(8):1503-1518. PubMed ID: 36165528
[TBL] [Abstract][Full Text] [Related]
5. Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma.
Wang G; Liu P; Li J; Jin K; Zheng X; Xie L
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891325
[TBL] [Abstract][Full Text] [Related]
6. Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma.
Yin Z; Zhou M; Liao T; Xu J; Fan J; Deng J; Jin Y
Front Oncol; 2021; 11():673567. PubMed ID: 35083132
[TBL] [Abstract][Full Text] [Related]
7. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
Xu M; Li Q; Zhang J; Xie H
Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
[TBL] [Abstract][Full Text] [Related]
8. An immune-related lncRNA risk coefficient model to predict the outcomes in clear cell renal cell carcinoma.
Tang C; Qu G; Xu Y; Yang G; Wang J; Xiang M
Aging (Albany NY); 2021 Dec; 13(24):26046-26062. PubMed ID: 34954690
[TBL] [Abstract][Full Text] [Related]
9. Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients.
Li Z; Wei J; Zheng H; Gan X; Song M; Zhang Y; Jin Y
Medicine (Baltimore); 2022 Jan; 101(1):e28531. PubMed ID: 35029920
[TBL] [Abstract][Full Text] [Related]
10. Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma.
Wei SY; Feng B; Bi M; Guo HY; Ning SW; Cui R
BMC Med Genomics; 2022 Dec; 15(1):263. PubMed ID: 36528763
[TBL] [Abstract][Full Text] [Related]
11. A novel necroptosis-related long noncoding RNA model for predicting clinical features, immune characteristics, and therapeutic response in clear cell renal cell carcinoma.
Zhang L; Chen Y; Hu W; Wu B; Ye L; Wang D; Bai T
Front Immunol; 2023; 14():1230267. PubMed ID: 37600792
[TBL] [Abstract][Full Text] [Related]
12. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma.
Wang Y; Zhang X; Dai X; He D
Expert Rev Anticancer Ther; 2021 Oct; 21(10):1161-1170. PubMed ID: 34319826
[No Abstract] [Full Text] [Related]
13. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.
Shen S; Chen X; Hu X; Huo J; Luo L; Zhou X
Cancer Med; 2021 Sep; 10(18):6561-6575. PubMed ID: 34378851
[TBL] [Abstract][Full Text] [Related]
14. A novel coagulation-related lncRNA predicts the prognosis and immune of clear cell renal cell carcinoma.
Wu W; Chang F; Zhang J; Tang S; Lv Z; Chen F
Sci Rep; 2023 Sep; 13(1):16302. PubMed ID: 37770494
[TBL] [Abstract][Full Text] [Related]
15. Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma.
Hong W; Liang L; Gu Y; Qi Z; Qiu H; Yang X; Zeng W; Ma L; Xie J
Mol Ther Nucleic Acids; 2020 Dec; 22():937-947. PubMed ID: 33251044
[TBL] [Abstract][Full Text] [Related]
16. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
[TBL] [Abstract][Full Text] [Related]
17. Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma.
Yin J; Li X; Lv C; He X; Luo X; Li S; Hu W
Front Mol Biosci; 2021; 8():689224. PubMed ID: 34327215
[No Abstract] [Full Text] [Related]
18. Upregulation of CCNB2 and a novel lncRNAs-related risk model predict prognosis in clear cell renal cell carcinoma.
Ren C; Wang Q; Xu Z; Pan Y; Wang S; Liu X
J Cancer Res Clin Oncol; 2024 Feb; 150(2):64. PubMed ID: 38300330
[TBL] [Abstract][Full Text] [Related]
19. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
20. Identification and experimental validation of a tumor-infiltrating lymphocytes-related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma.
Deng Y; Guo K; Tang Z; Feng Y; Cai S; Ye J; Xi Y; Li J; Liu R; Cai C; Tan Z; Zhang Y; Han Z; Zeng G; Zhong W
Front Immunol; 2022; 13():1046790. PubMed ID: 36505457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
